FDA DEVICE FACTS
BIOFOAM Bone Wedge
Wrightmedicaltechnologyinc
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The BIOFOAM® Bone Wedge is intended to be used for internal bone fixation for bone fractures, fusions, or osteotomies in the ankle and foot, such as: e Cotton and Evans Wedges: * Opening wedge osteotomies of the bones of the foot including osteotomies for Hallux Valgus * Opening wedge of Medial Cuneiform or Cotton osteotomies « Lateral Column Lengthening (Evans Lengthening Osteotomy or Calcaneal Z Osteotomy) * Metatarsal/Cuneiform arthrodesis e Midfoot Wedges * Opening wedge osteotomies of the bones of the foot including osteotomies for Hallux Valgus * Nonunion of arthrodesis of the Midfoot including Metatarsal/Cuneiform arthrodesis (TMT or Lapidus) This device is intended for use with ancillary fixation. The BIOFOAM® Bone Wedge is not intended for use in the spine.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。